{"count": 2, "results": [{"_id": "35598008", "pmid": 35598008, "pmcid": "PMC9124394", "title": "Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial", "journal": "BMC Musculoskelet Disord", "authors": ["Ruan G", "Yuan S", "Lou A", "Mo Y", "Qu Y", "Guo D", "Guan S", "Zhang Y", "Lan X", "Luo J", "Mei Y", "Zhang H", "Wu W", "Dai L", "Yu Q", "Cai X", "Ding C"], "date": "2022-05-21T00:00:00Z", "doi": "10.1186/s12891-022-05434-2", "meta_date_publication": "2022 May 21", "meta_volume": "23", "meta_issue": "1", "meta_pages": "486", "score": 50252.035, "text_hl": "Can @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ relieve tibiofemoral @DISEASE_Cartilage_Diseases @DISEASE_MESH:D002357 @@@cartilage volume loss@@@ and @<m>DISEASE_Knee_Fractures</m> @DISEASE_MESH:D000092443 @@@knee symptoms@@@ in @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@ @DISEASE_Osteoarthritis_Knee @DISEASE_MESH:D020370 @@@knee osteoarthritis@@@ @SPECIES_9606 @@@patients@@@? ", "citations": {"NLM": "Ruan G, Yuan S, Lou A, Mo Y, Qu Y, Guo D, Guan S, Zhang Y, Lan X, Luo J, Mei Y, Zhang H, Wu W, Dai L, Yu Q, Cai X, Ding C. Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial BMC Musculoskelet Disord. 2022 May 21;23(1):486. PMID: 35598008", "BibTeX": "@article{35598008, title={Can metformin relieve tibiofemoral cartilage volume loss and knee symptoms in overweight knee osteoarthritis patients? Study protocol for a randomized, double-blind, and placebo-controlled trial}, author={Ruan G and Yuan S and Lou A and Mo Y and Qu Y and Guo D and Guan S and Zhang Y and Lan X and Luo J and Mei Y and Zhang H and Wu W and Dai L and Yu Q and Cai X and Ding C}, journal={BMC Musculoskelet Disord}, volume={23}, number={1}, pages={486}}"}}, {"_id": "40381663", "pmid": 40381663, "title": "Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway.", "journal": "Biochem Pharmacol", "authors": ["Jiaxin F", "Xiang J", "YongPing C", "Kainan L", "Tianjie X", "Hui Z", "Shiqing S", "Cao Y", "Qian W"], "date": "2025-08-01T00:00:00Z", "doi": "10.1016/j.bcp.2025.116978", "meta_date_publication": "2025 Aug", "meta_volume": "238", "meta_issue": "", "meta_pages": "116978", "score": 50247.746, "text_hl": "The study found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ significantly inhibits chondrocyte ferroptosis by upregulating @GENE_SLC7A11 @GENE_310392 @@@SLC7A11@@@ and downregulating @GENE_P53_PS @GENE_301300 @@@P53@@@ expression, maintaining the balance of synthesis and catabolism in chondrocytes, and effectively slowing down the @<m>DISEASE_Knee_Fractures</m> @DISEASE_MESH:D000092443 @@@degeneration of knee joint cartilage@@@ in @SPECIES_10116 @@@rats@@@. ", "citations": {"NLM": "Jiaxin F, Xiang J, YongPing C, Kainan L, Tianjie X, Hui Z, Shiqing S, Cao Y, Qian W. Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway. Biochem Pharmacol. 2025 Aug;238():116978. PMID: 40381663", "BibTeX": "@article{40381663, title={Metformin exhibits inhibitory effects on ferroptosis and alleviates chondrocyte metabolic imbalance in osteoarthritis models, as well as Erastin-induced ferroptosis, through the modulation of the P53/SLC7A11 pathway.}, author={Jiaxin F and Xiang J and YongPing C and Kainan L and Tianjie X and Hui Z and Shiqing S and Cao Y and Qian W}, journal={Biochem Pharmacol}, volume={238}, pages={116978}}"}}]}